Botswana vs North Macedonia: Share of adolescent girls vaccinated against human papillomavirus
Botswana
16.0%
in 2024
North Macedonia
21.0%
in 2024
Botswana rank
68th
North Macedonia rank
67th
Share of adolescent girls vaccinated against human papillomavirus over time
- Botswana
- North Macedonia
How they compare
North Macedonia currently reports 21.0% against 16.0% in Botswana, a difference of 5.0%.
That makes North Macedonia's figure about 1.3 times Botswana's.
The two have swapped places 2 times across 9 shared years of data; in 2016 it was North Macedonia ahead.
Botswana ranks 68th and North Macedonia ranks 67th of 74 countries.
Botswana has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Botswana | North Macedonia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 53.5% | 40.2% | 13.2% | Botswana |
| 2020s | 42.6% | 35.0% | 7.6% | Botswana |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of adolescent girls vaccinated against human papillomavirus, Botswana or North Macedonia?
- North Macedonia, at 21.0% against 16.0% in Botswana as of 2024.
- What is the difference in share of adolescent girls vaccinated against human papillomavirus between Botswana and North Macedonia?
- 5.0%, with North Macedonia ahead.
- How many years of comparable data are there for Botswana and North Macedonia?
- 9 years are reported by both, from 2016 to 2024.
- How do Botswana and North Macedonia rank globally for share of adolescent girls vaccinated against human papillomavirus?
- Botswana ranks 68th and North Macedonia ranks 67th of 74 countries.
- Where does this data come from?
- WHO & UNICEF (2025) – processed by Our World in Data, published as Share of adolescent girls vaccinated against human papillomavirus. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Share of fifteen-year-old girls who, between the ages of 9 and 14, received their last dose of the human papillomavirus vaccine.